Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Masimo Corp Market Cap
From what 6 stock analysts predict, the share price for Masimo Corp (MASI) might decrease by 15.49% in the next year. This is based on a 12-month average estimation for MASI. Price targets go from $70.00 to $145.00. The majority of stock analysts believe MASI is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 6 Wall Street analysts have assignedMASI 2 buy ratings, 4 hold ratings, and 0 sell ratings. This means that analysts expect Masimo Corp to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on MASI. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| vik chopra Wells Fargo | Hold | $117.0 | maintained | Feb 6, 2024 |
| michael polark Wolfe Research | Buy | $145.0 | maintained | Feb 2, 2024 |
| marie thibault BTIG | Buy | $145.0 | reiterated | Jan 31, 2024 |
| matthew taylor Jefferies | Hold | $121.0 | downgraded | Jan 29, 2024 |
| michael matson Needham | Hold | None | maintained | Jan 22, 2024 |
| rick wise Stifel Nicolaus | Hold | $125.0 | maintained | Jan 10, 2024 |
| larry biegelsen Wells Fargo | Hold | $81.0 | maintained | Dec 13, 2023 |
| jason bednar Piper Sandler | Hold | $70.0 | rated | Nov 29, 2023 |
| jayson bedford Raymond James | Hold | None | downgraded | Nov 8, 2023 |
| ryan zimmerman BTIG | Buy | $200.0 | maintained | Apr 17, 2023 |
| jason wittes Loop Capital Markets | Buy | $180.0 | maintained | Mar 1, 2023 |
| ravi misra Berenberg Bank | Hold | None | rated | Dec 13, 2021 |
| lawrence keusch Raymond James | Buy | $285.0 | maintained | Apr 26, 2021 |
| john hsu Raymond James | Hold | None | maintained | Aug 2, 2018 |
| joanne wuensch Citigroup | Hold | $24.0 | rated | Aug 8, 2014 |
| ben haynor Alliance Global Partners | Hold | $26.0 | reiterated | Oct 31, 2013 |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
When did it IPO
2007
Staff Count
4,000
Country
United States
Sector/Industry
Healthcare/Medical Devices
CEO
Mr. Joseph E. Kiani
Market Cap
$7.12B
In 2023, MASI generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that MASI's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
ALTR-USD
$89.86
RGLD-USD
$108.65
LYFT-USD
$17.91
HAS-USD
$50.19
CROX-USD
$115.72
HQY-USD
$81.33
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
